Profile
Dr. Don B. Rix, MD, is Chairman at MDS Metro Laboratory Services, Inc., Chairman at PrioNet Canada, and a Principal at Rix Venture Capital (VCC) Corp.
He is on the Board of Directors at Sirius Genomics, Inc., Perceptronix Medical, Inc., Premier's Technology Council, and BC Children's Hospital Foundation.
Dr. Rix was previously employed as Chairman by Quest PharmaTech, Inc., Chairman by BC Advantage Funds, Chairman by British Columbia Innovation Council, Chairman by CANTEST Ltd., Chairman by Lions Capital Corp., and Special Limited Partner by Yaletown Venture Partners, Inc. He also served on the board at Apex Bioventures Acquisition Corp., Protox Therapeutics, Inc., Resverlogix Corp., and Amorfix Life Sciences Ltd.
He received his undergraduate degree from the University of Western Ontario and a doctorate degree from the University of Western Ontario.
Former positions of Don B. Rix
| Companies | Position | End |
|---|---|---|
Lions Capital Corp.
Lions Capital Corp. Investment ManagersFinance Lions Capital invests in companies located in Canada. The firm targets companies operating in the fields of technology, life science and clean tech. They provide financing for early stage requirements. | Chairman | 2010-06-29 |
Yaletown Venture Partners, Inc.
Yaletown Venture Partners, Inc. Investment ManagersFinance Yaletown Partners invests in companies located in Canada. The firm focuses on companies operating in the fields of emerging growth technology companies. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 2-4 million. It also makes follow on investment. | Corporate Officer/Principal | 2009-12-30 |
LifeLabs, Inc.
LifeLabs, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic laboratory testing services | Chairman | 2009-11-05 |
Rix Venture Capital (VCC) Corp.
Rix Venture Capital (VCC) Corp. MiscellaneousMiscellaneous Investment vehicle | Chairman | 2009-03-23 |
Premier's Technology Council
Premier's Technology Council General GovernmentGovernment Promotes economic development through technology | Director/Board Member | 2009-11-05 |
Training of Don B. Rix
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Quest PharmaTech, Inc.
Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
BC Advantage Funds Ltd.
BC Advantage Funds Ltd. Investment ManagersFinance BC Advantage Funds (VCC) Ltd invests invests in emerging life science, technology and clean companies located in British Columbia. Its portfolio includes investments in biotech and medical devices as well as information technology, manufacturing and clean technology companies. The firm makes investments in private and public companies. It invests in early stage transactions. | Finance |
Perceptronix Medical, Inc.
Perceptronix Medical, Inc. Medical/Nursing ServicesHealth Services Develops cytology laboratory and cancer diagnostics | Health Services |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance Blank check company | Finance |
Yaletown Venture Partners, Inc.
Yaletown Venture Partners, Inc. Investment ManagersFinance Yaletown Partners invests in companies located in Canada. The firm focuses on companies operating in the fields of emerging growth technology companies. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 2-4 million. It also makes follow on investment. | Finance |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CANTEST Ltd.
CANTEST Ltd. Miscellaneous Commercial ServicesCommercial Services Provides analytical testing and consultation services | Commercial Services |
LifeLabs, Inc.
LifeLabs, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic laboratory testing services | Commercial Services |
Innovate BC
Innovate BC Miscellaneous Commercial ServicesCommercial Services Develops entrepreneurial talent and supports commercializing technology | Commercial Services |
Lions Capital Corp.
Lions Capital Corp. Investment ManagersFinance Lions Capital invests in companies located in Canada. The firm targets companies operating in the fields of technology, life science and clean tech. They provide financing for early stage requirements. | Finance |
Premier's Technology Council
Premier's Technology Council General GovernmentGovernment Promotes economic development through technology | Government |
BC Children's Hospital Foundation
BC Children's Hospital Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
PrioNet Canada
PrioNet Canada PrioNet Canada developed strategies to eradicate prion diseases such as mad cow and Creutzfeldt - Jakob disease. The company was headquartered in Vancouver, Canada. | |
Rix Venture Capital (VCC) Corp.
Rix Venture Capital (VCC) Corp. MiscellaneousMiscellaneous Investment vehicle | Miscellaneous |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Develops DNA-based diagnostic and pharmacogenetic products | Health Technology |
- Stock Market
- Insiders
- Don B. Rix
















